Alchemab Therapeutics reveals Alzheimer’s candidate
ATLX-1088 is regarded as a possible first-in-class human antibody targeting CD33 – a cell surface protein
Read More
Tag: Alzheimer’s
Axol and StrataStem link up for Alzheimer’s disease trial
Companies will incorporate cells and technology to create a ‘clinical trial in a dish’
Read More
Vital patent for AlzeCure Alzheimer’s drug
ACD856 is the leading candidate therapy on the company’s NeuroRestore platform
Read More
AlzeCure begins Alzheimer’s therapy development phase
Candidate will go through the development programme, which includes safety and tolerability studies
Read More
AlzeCure gets new Alzheimer’s abstract accepted
Therapy is based on ACD856’s indicative disease modifying effects against the condition
Read More
AlzeCure’s Alzheimer’s candidate shows promise
Treatment abstract focuses on results from a multiple ascending dose study in healthy volunteers
Read More
Blood vessel breakthrough is major step towards Alzheimer’s treatment
The discovery may lead to development of drugs that halt disease progression and stop memory loss
Read More
Biogen, Sangamo team up on neurological diseases
The companies have detailed plans to leverage Sangamo’s proprietary zinc finger protein (ZFP) technology.
Read More
‘Smart watches’ for Alzheimer’s discussed as numbers set to double by 2050
Alzheimer’s is a complex disease and one of the largest challenges facing healthcare today, with lots of failed treatments in past pipelines.
Read More
Another mid-late stage Alzheimer’s flop, this time for Lilly
Earlier this month, Roche also announced a gantenerumab Alzheimer’s failure, and last year Biogen and Eisai stopped two global Phase III trials of aducanumab.
Read More
Alzheimer’s charity launches mass survey
Alzheimer’s is a complex disease with lots of failed treatments in past pipelines.
Read More
New blood test ‘highly accurate’ at early Alzheimer’s identification
The test can measure levels of the Alzheimer’s protein amyloid beta in the blood.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
